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Abstract: The leptin gene (LEP) plays a regulatory role in satiety, inflammation, and allergy. Prior findings linking 
leptin to asthma motivated us to investigate whether DNA methylation (DNA-M) of CpG (cytosine-phosphate-gua-
nine) sites in concert with single nucleotide polymorphisms (SNPs) of LEP can explain the risk of asthma and lung 
function. Methylation of CpG sites was assessed using the Illumina Infinium Human Methylation 450 beadchip in 
blood samples collected from 10- and 18-year-old boys and girls from the Isle of Wight (IOW) birth cohort (UK). Four 
LEP SNPs were genotyped. Linear and log linear models were used for the analysis, adjusting for false discovery rate 
(FDR). The analyses were repeated in the BAMSE cohort (Sweden). In the IOW study, the interaction of cg00666422 
and rs11763517 (CT vs TT and CC) was associated with FEV1 (FDR-adjusted p-value: 0.03), FEV1/FVC ratio (FDR-
adjusted p-value: 0.0096), and FEF25-75% (FDR-adjusted p-value: 0.00048) such that they decreased with increas-
ing DNA-M. The interaction of the same CpG-SNP pair was also associated with increased risk of asthma at age 18. 
We replicated the findings for FEV1/FVC and FEF25-75% in a smaller sample of 34 participants at age 10. Regarding 
the BAMSE cohort, although, the interaction of cg00666422 and rs11763517 on lung function were not significant, 
the direction of the effect was the same as in IOW cohort. Thus, penetrance of LEP genotype seems to be modified 
by methylation at cg00666422 and is linked to airway obstruction and asthma.
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Introduction
Asthma represents a major public health bur-
den. It is a chronic disease characterized by the 
airway inflammation and bronchial hyperre-
sponsiveness [1]. Studies have shown that 
around 60% of asthma is heritable and that 
several genetic factors are associated with the 
heritability of asthma across generations [2]. 
The leptin (LEP) gene, encoding a 16 kDa pleio-
tropic adipokine, is one such gene that plays a 
regulatory role in inflammation in asthma and 
allergic responses [3]. In addition to being ex- 
pressed in adipocytes, leptin and the leptin 
receptor are both expressed in bronchial epi-
thelial cells and alveolar macrophages [4].
The relationship between asthma and leptin 
has been explored in several experimental and 
observational studies. Shore et al. found that 
serum leptin levels increased during allergic 
reactions [5]. Kattan et al. reported that leptin 
levels were positively correlated with asthma 
symptoms in girls [6]. In another study by Hi- 
ckson, lung function was found to be inversely 
associated with serum leptin levels in African 
Americans [7]. Newson et al. have shown that 
leptin and leptin/adiponectin ratios are associ-
ated with asthma [8].
Though these studies indicate an association 
between leptin levels and asthma, the biologi-
cal mechanisms underlying these relationships 
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are unknown. The role of single nucleotide po- 
lymorphisms (SNPs) in LEP gene has been 
explored: Szczepankiewicz et al. reported the 
LEP 3’UTR A/G (rs13228377) and the -2549T/
G (rs2167270) polymorphisms to be signifi-
cantly associated with asthma. LEP is also a 
candidate gene for obstructive sleep apnea 
syndrome, which is an independent risk factor 
for asthma [9].
Apart from genetic polymorphisms, epigenetic 
mechanisms may also influence disease risk. 
DNA methylation (DNA-M) is one such epige- 
netic mechanism that alters gene expression 
without changing the DNA sequence [10]. It 
involves addition of methyl groups to cytosine 
bases in cytosine-phosphate-guanine (CpG) di- 
nucleotides. DNA-M offers a potential mecha-
nism through which the environment can affect 
gene expression [11], and so gene × environ- 
ment interactions may be reflected at the DNA 
methylation level, especially for diseases such 
as allergy where there is a large environmental 
component to disease risk. While SNPs may 
affect outcomes at the population level, the 
effect of SNPs represents the average effect 
of a given genotype across a wide range of 
environments. It is therefore important to an- 
alyze interactions between SNP genotype and 
DNA-M, to detect different effects of genotype 
depending on environmental factors.
Findings that linked leptin to asthma and lung 
function [6-8] motivated us to investigate 
whether DNA-M of the LEP gene in concert with 
genetic polymorphisms of this gene can explain 
the risk of lung function and asthma. In particu-
lar, we hypothesize that the penetrance of the 
LEP gene variants for lung function and asthma 
is moderated by its methylation, as proposed 
for other genes [11, 12]. To test this hypothesis 
we analyzed interactions of LEP SNPs and CpG 
sites on lung function and asthma outcomes in 
10-year-old girls, and 18-year-old men and 
women in the Isle of Wight birth cohort. The sig-
nificant CpG and SNP interactions were tested 
in an independent BAMSE cohort for replication 
of the results.
Methods
Isle of wight cohort
Study population: A whole population birth co- 
hort was established on the Isle of Wight, UK, in 
1989 to prospectively study the natural history 
of allergies and asthma. 1,456 of the 1,536 
children born between January 1, 1989 and 
February 28, 1990 were enrolled in the study 
(F1 generation) after exclusion of adoptions, 
perinatal deaths, and refusals to participate. 
Ethical approvals were obtained from Local 
Research Ethics Committees (last: NRES Co- 
mmittee South Central-Hampshire B) and in- 
formed consents were obtained for all the par-
ticipants at recruitment and at each follow up 
at ages of 1, 2, 4, 10, and 18 years (n=1,313). 
The birth cohort has been described in detail 
elsewhere [13]. Detailed interviews and exami-
nations were completed for each child at follow 
up. A postal or telephone questionnaire was 
sent if a visit was not possible [14]. This study 
focusses on 125 men and 245 women at age 
18 who had measurement of DNA-M, and a 
subset of these women at age 10 (n=34) ran-
domly selected for DNA-M analysis.
SNP selection and genotyping: The genotype 
tagging system scheme used to tag the SNPs 
gave priority to the variants that showed strong 
association with asthma in the Isle of Wight 
birth cohort, or had been reported by others to 
be associated with asthma, or allergy and have 
functional importance (non-synonymous, locat-
ed in conserved regions of DNA or present in 
regulatory regions). LEP SNPs (including 10 kb 
upstream and downstream of the gene) were 
determined using the tagger implemented in 
Haploview 3.2 based on Caucasian HapMap 
data. The threshold value for r2 was taken as 
0.2 for tagging and one, two, and three SNP 
marker combination tests were used [10]. Four 
LEP SNPS were selected. DNA extracted from 
blood or saliva samples of 1,211 cohort sub-
jects were interrogated using Golden Gate 
Genotyping Assays (Illumina Inc, San Diego, CA) 
on the Bead Xpress Veracode platform per 
Illumina’s protocol. DNA from each subject plus 
37 replicate samples were analyzed. The quali-
ty threshold for allele determination was set at 
a GenCall score >0.25 with 98.3% retained for 
further analysis. Analysis of each locus includ-
ed reclustering of genotyping data using our 
project data to define genotype cluster posi-
tions with additional manual reclustering to 
maximize both cluster separation and the 50th 
percentile of the distribution of the GenCall 
scores across all genotypes (50% GC score) 
[14].
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DNA methylation analysis: DNA was extracted 
from peripheral blood samples using a salting 
out procedure [15] and its concentration was 
determined by Qubit quantitation. One micro-
gram of DNA was bisulfite treated using the EZ 
96-DNA methylation kit (Zymo Research, CA, 
USA), following the manufacturer’s standard 
protocol. Genome-wide DNA methylation was 
assessed using the Illumina Infinium Human 
Methylation 450 beadchip (Illumina, Inc., CA, 
USA), which interrogates >484,000 CpG sites 
associated with approximately 24,000 genes. 
Arrays were processed and imaged using the 
manufacturer’s recommendations. To estimate 
assay variability, multiple identical control sam-
ples were assigned to each bisulfite conversion 
batch. To control against batch effects the sam-
ples were randomly distributed on microarrays. 
The methylation level (β value) was calculated 
for each queried CpG locus using the methyla-
tion module of GenomeStudio software [10]. 
DNA methylation levels for each CpG were esti-
mated as the proportion of intensity of methyl-
ated (M) over the sum of methylated (M) and 
unmethylated (U) probes, β=M/[c+M+U] with c 
being a constant to prevent dividing by zero 
[16]. Methylation data were preprocessed and 
batch-effect removed using Bioconductor pack-
ages IMA [17] and ComBat. DNA-M was 
assessed in 125 men and 245 women at age 
18. Of these 245 women, 34 also provided a 
blood sample at age 10 for DNA-M analysis.
Clinical data collection and outcomes: Maternal 
and paternal histories of asthma, and maternal 
smoking status during pregnancy were obtained 
at birth. Height and weight of the child were 
measured and questionnaires were completed 
at follow-ups at ages 1, 2, 4, 10, and 18. 
Current smoking status was obtained at 18 
years of age. Asthma at age 18 was determined 
using the International Study of Asthma and 
Allergies in Childhood (ISAAC) questionnaire 
[18] defined as a physician diagnosed asthma 
plus current symptoms and/or asthma medica-
tions [10].
Serum leptin concentrations were measured in 
blood samples collected at 18 years of age 
using an enzyme-linked immunosorbent assay 
(Biokit, S.A.; Barcelona, Spain) following the 
manufacturer’s kit instructions. Each sample, 
standards, and blank were assayed in du- 
plicates.
Lung function outcomes were assessed using 
the KoKo spirometry software package on a 
portable desktop device (PDS Instrumentation, 
Louisville, KY, USA) [19]. Tests were performed 
following the guidelines of the American Th- 
oracic Society and European Respiratory Soci- 
ety [20]. Lung function outcomes and serum 
leptin levels were also measured at age 10. 
Participants were required to be free from re- 
spiratory infection for 14 days and not adminis-
tering any systemic oral steroids. It was also 
necessary that they did not take any short-act-
ing beta-2 agonist for at least 6 hours, long-
acting beta-2 agonist for 12 hours and caffeine 
for at least 4 hours prior to testing. All the mea-
surements were made with the participants in 
the standing position without using a nose clip. 
The best of three consecutive expiratory ma- 
neuvers of forced vital capacity (FVC), forced 
expiratory volume 1 (FEV1), the FEV1/FVC ratio, 
and forced expiratory flow 25-75% (FEF25-75%) 
were taken as final values. Participants who 
had symptoms of asthma or were on antibiotics 
or steroids were rescheduled for spirometry.
Statistical analysis: Genome Studio software 
was used to process the raw methylation inten-
sities and the detection p-value for each CpG 
was used as a QC measure of probe perfor-
mance. CpG sites that had detection P values 
>0.01 in >10% of the samples, and CpG sites 
with probe-SNPs, were excluded from all analy-
ses. Statistical analyses were performed using 
the SAS statistical package (version 9.3; SAS 
Institute, Cary, NC, USA).  Our analytical sam-
ples included 370 men and women at age 18, 
and 34 girls at 10 years, with DNA methylation 
data. We performed chi square analyses to 
assess whether these samples were represen-
tative of the total cohort. To identify haplotype 
blocks for the SNPs, linkage disequilibrium (LD) 
analysis was performed on 4 LEP SNPs with 
Haploview 4.2.
The statistical analysis was divided into two 
parts. First, via linear regressions, we exam-
ined whether the interaction of LEP SNPs and 
DNA methylation was associated with lung 
function outcomes (FVC, FEV1, FEF25-75%), ex- 
haled nitric oxide (eNO), and serum leptin levels 
at 18 years of age. More women than men were 
included in this study due to an initial research 
focus on pregnancy. To account for this imbal-
ance, all the linear regression models were 
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Table 1. Comparison of population characteristics of participants in the whole cohort with those with 
DNA methylation data in IOW cohort
Parameter Total cohort n=1313 Participants with DNA-M  data at age 18 n=370 p-value
Median (5%, 95% value); n
Height
    Boys 178 (167, 190); 483 177.3 (167, 187.3); 124 0.3
    Girls 164 (154.5, 175); 511 165 (154, 176); 243 0.44
Weight
    Boys 69 (55.6, 91.2); 468 70 (56, 97.2); 123 0.38
    Girls 61.14 (48.5, 90.1); 502 61.45 (50.4, 89.1); 240 0.63
BMI
    Boys 21.7 (18.1, 30.0); 465 21.85 (18.3, 29.1); 123 0.38
    Girls 22.86 (18.2, 13.7); 499 22.88 (19.1, 32.9); 240 0.57
FVC
    Boys 5.34 (4.21, 6.60); 395 5.34 (4.11, 6.70); 119 0.99
    Girls 3.98 (3.1, 4.8); 443 4.05 (3.19, 5.02); 237 0.07
FEV1
    Boys 4.55 (3.64, 5.63); 396 4.57 (3.59, 5.62); 119 0.59
    Girls 3.48 (2.72,4.17); 443 3.54 (2.81, 4.26); 237 0.08
FEV1/FVC
    Boys 0.87 (0.74, 0.98); 396 0.87 (0.77, 0.99); 119 0.6
    Girls 0.88 (0.75, 0.98); 443 0.88 (0.75, 0.98); 237 0.66
FEF25-75%
    Boys 4.97 (3.23, 6.84); 396 5.12 (3.42, 6.94); 119 0.42
    Girls 4.00 (2.5, 5.4); 443 4.05 (2.55, 5.42); 237 0.33
ENO
    Boys 19.0 (7, 108); 387 18.00 (7, 78); 113 0.27
    Girls 14.0 (5, 64); 435 13.00 (6, 64); 234 0.26
Serum leptin (ng/ml)
    Boys 1.22 (0.40, 13.11); 288 1.2 (0.40, 16.04); 120 0.99
    Girls 13.11 (2.4, 54.57); 265 13.11 (2.76, 54.57); 239 0.7
Maternal asthma during pregnancy 0.41
    Yes 137 (10.51) 44 (12.02)
    No 1167 (89.49) 322 (87.98)
Paternal asthma 0.23
    Yes 128 (9.88) 43 (11.88)
    No 1168 (90.12) 319 (88.12)
Atopy Status
    Boys 194 (47.7) 50 (40.6) 0.17
    Girls 159 (35.65) 76 (31.4) 0.26
Maternal smoking status 0.23
    Yes 305 (23.34) 75 (20.83)
    No 1002 (76.66) 293 (79.62)
Current smoking status 0.29
    Yes 368 (28.79) 95 (25.96)
    No 910 (71.21) 271 (74.04)
Sex <0.0001
    Male 653 (49.73) 125 (33.78)
    Female 660 (50.3) 245 (66.22)
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weighted by sex proportions. Multiple testing 
was adjusted by controlling false discovery rate 
(FDR) of 0.05. This was followed by a replicato-
ry step in which we repeated the analyses 
focussing on lung function outcomes and inter-
action of SNP and DNA-M in the 34 girls at 10 
years of age. Since the interaction terms should 
be independent of each other, we also tested 
whether SNPs explained the methylation of 
CpG sites, also called genotype-dependent 
methylation [21]. If this was the case, we esti-
mated the residuals of the CpG after the 
respective SNP was adjusted for. The methyla-
tion residuals are no longer dependent on the 
SNP and the combined effect of methylation 
residuals with SNPs then facilitates an unbi-
ased assessment of the interaction.
In the second part of the analysis, we assessed 
whether the CpG and SNP pairs surviving FDR 
in the first step were associated with asthma at 
age 18. The analysis was controlled for mater-
nal and paternal asthma, maternal smoking, 
and current smoking status, height, and weight 
of the participants.
The BAMSE cohort
Study population: The CpG and SNP interaction 
terms that were found to be significantly asso-
ciated with lung function in the Isle of Wight 
birth cohort were tested in the data from 
BAMSE prospective birth cohort, Sweden. Pa- 
rents of children (n=7,221) born between Fe- 
bruary 1994 to November 1996 in Northern 
and Central Stockholm were asked to partici-
pate in the study. After excluding non-respond-
ers and ineligible participants, a total of 4,089 
children were enrolled. The cohort is described 
in detail elsewhere [22, 23]. Epigenome-wide 
DNA-M was measured DNA extracted from 
blood samples collected from 472 children at 8 
years of age. Bisulphite conversion of 500 ng 
DNA per sample was done by using the EZ-96 
DNA Methylation kit (Shallow; Zymo Research 
Corporation, Irvine, USA). Samples were pro-
Table 2. Distributions of DNA-M at LEP CpG sites, in whole blood samples at age 18 in IOW cohort
Subpopulation with methylation (n=370)
CpG site Location  (genome v37) Coordinate Mean Median 5% 95% Std Dev
cg14734794 127879920 TSS1500 0.96 0.96 0.95 0.97 0.01
cg12782180 127880932 TSS1500 0.43 0.43 0.33 0.52 0.06
cg00840332 127881269 TSS200 0.17 0.16 0.10 0.24 0.04
cg00666422 127881440 5’UTR 0.45 0.46 0.36 0.54 0.05
cg12083122 127883819 5’UTR 0.95 0.95 0.94 0.97 0.01
cg25435800 127890193 5’UTR 0.94 0.94 0.90 0.97 0.02
cg25730670 127891366 5’UTR 0.95 0.95 0.93 0.96 0.01
cg24862443 127896859 3’UTR 0.94 0.94 0.93 0.95 0.01
5’UTR=5’ untranslated region; TSS200=within 200 bp of the transcription start site; TSSS1500=within 1500 bp of the tran-
scription start site.
Figure 1. Linkage disequilibrium plot of LEP SNPs, 
standard (D’/LOD) color scheme; D’ LD values are 
displayed.
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cessed with the Illumina Infinium HumanMe- 
thylation450 BeadChip (Illumina Inc., San Di- 
ego, USA) [24]. Pre-processing of the DNA-M 
data, and quality control were performed by 
using standard criteria and samples with a call 
rate <99%, color balance >3, or low median 
Results
The Isle of wight cohort
There were no significant differences in bo- 
dy mass index (BMI), current smoking status, 
Figure 2. Comparison of rs11763517 genotypes in interaction with cat-
egorized methylation levels of cg00666422 on (A) FEV1 (B) FEV1/FVC 
and (C) FEF25-75% at age 18. The horizontal axis represents the bins 
of DNA methylation, and the green bars represent the frequency for the 
DNA methylation bins. For example, 34 individuals have a DNA methyla-
tion level of 39%-41%. The CT genotype (red dots) and the TT and CC 
(combined) genotype (black diamonds) are plotted against (A) FEV1 (B) 
FEV1/FVC and (C) FEF25-75%. The reference genotype was TT and CC 
combined.
intensity were excluded from the 
analysis. Lung function testing 
was performed at 8 years of age 
using the 2200 Pulmonary Fu- 
nction Laboratory (Sensormedi- 
cs, Anaheim, CA, USA) and at 16 
years with the Jaeger Master- 
Screen-IOS system (Carefusion 
Technologies, San Diego, Califor- 
nia) [25]. The highest values of 
forced expiratory volume in 1 sec 
(FEV1) were extracted and used 
from analysis, provided that the 
subject’s effort was coded as 
being maximal by the test leader, 
the flow-volume curve passed 
visual quality inspection, and 
that the two highest FEV1 read-
ings were reproducible according 
to ATS/ERS criteria. LEP geno-
types were extracted from GWAS 
data (Illumina 610quad chip with 
imputation from the 1000 ge- 
nomes project) available on 485 
selected Caucasian subjects as 
described earlier [26]. In total, 
343 and 294 BAMSE subjects 
had complete data for this study, 
i.e. lung function data at 8 and 
16 years, respectively, as well as 
genotype and methylation data.
Statistical analysis: Linear re- 
gression models were used to 
test the significant interaction 
terms of CpGs (measured at age 
8) and SNPs with lung function 
markers as dependent variables 
for both boys and girls at ages 8 
and 16. The models were adjust-
ed for maternal asthma, paternal 
asthma, height, weight, maternal 
smoking, current smoking, and 
were weighted by sex. Successful 
replication was defined as having 
the same direction of effect and 
a p-value of less than 0.05.
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maternal smoking status, maternal asthma or 
paternal asthma, between the participants of 
the whole cohort (n=1,313) and the subset of 
participants for whom DNA methylation data 
was collected (n=370) (Table 1). Methylation 
levels of CpG sites within LEP at age 18 are 
shown in Table 2. Seven CpG sites were remo- 
ved after data cleaning and one CpG with a 
probe-SNP was excluded from the analysis. The 
eight remaining CpG sites have low, medium, 
and high levels of methylation (Table 2, median 
β: range 0.16 to 0.96).
Four SNPs were genotyped for the LEP gene. 
Out of these four, two were found to be in a 
single LD block when analyzed by Haplovi- 
ew 4.2. Thus, three uncorrelated SNPs were 
chosen for the analysis (Figure 1). The LEP 
gene SNPs rs4731429 and rs10954176 are 
located in the 3’UTR region, and the SNP 
rs11763517 is located in the first intron (Figure 
4, Table 3).
Effect of LEP SNPs, DNA-M, and their interac-
tion on lung function, and leptin levels: We ran 
multiple linear regression models to analyze 
the effect of LEP CpGs in interaction with SNPs 
on lung function outcomes, focusing on FVC 
and on obstructive markers, namely FEV1, the 
FEV1/FVC ratio, and FEF25-75%. Additionally, 
and p=0.026, respectively). In order to ensure 
that it is the DNA-M effect on the lung function, 
we removed the SNP effect from the methyla-
tion by running a regression model with cg- 
00666422 as the dependent variable and 
rs11763517 as the independent variable, and 
extracted the residuals from this model. We 
then assessed whether the interaction of these 
residuals with SNP rs11763517 had an asso-
ciation with the lung function outcomes. We 
found that FEV1/FVC and FEF25-75% were sig-
nificantly associated with the interaction of the 
residuals and rs11763517 in the same direc-
tion adjusting for the confounders indicating 
that original assessment was not biased. In 
addition, since for lung function the effect of 
the SNP followed a heterosis model (TT and CC 
were not different from one another), we com-
bined the genotypes TT and CC and estimated 
the risk for the CT genotype. Applying a hetero-
sis model, the methylation was no longer differ-
ently distributed on CT vs. TT and CC (p=0.74). 
Hence, also in a heterosis model the CpG site 
and the SNP were independent.
We repeated the analysis with all the eight CpG 
sites and three SNPs using the heterosis model. 
The analysis revealed that the interaction of 
the CpG cg00666422 and SNP rs11763517 
(CT vs TT and CC) was significantly associated 
Figure 3. Risk ratio of asthma at age 18 versus methylation of the LEP 
CpG site cg00666422, for rs11763517 genotype CT relative to TT or CC 
(combined). The horizontal axis represents bins of DNA methylation and 
the green bars represent the frequency for those DNA methylation bins. 
The CT genotype (red dots) is plotted against asthma relative risk. The 
reference genotype was TT and CC combined.
we also investigated exhaled nitric 
oxide, and serum leptin levels as 
outcomes. All models were adjust-
ed for height, weight, sex, current 
smoking status, maternal smok-
ing status, and maternal and pa- 
ternal asthma status. The signifi-
cant associations that survived 
FDR were the interactions of CpG 
cg00666422 and SNP rs1176- 
3517 (CT vs CC) with FEV1, FEV1/
FVC, and FEF25-75% at age 18. 
Exhaled nitric oxide and serum 
leptin levels were not found to be 
significantly related to this interac-
tion term.
Since interaction terms should be 
independent of each other, we 
tested whether rs11763517 expl- 
ained the methylation of cg00- 
666422. Indeed we found that, 
compared to the CC genotype, the 
TT genotype had a 3.6% and CT a 
1.5% lower methylation (p<0.0001 
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Table 3. Location and comparison of LEP SNPs in whole cohort and participants with DNA methyla-
tion
SNP Genotype Coordinate Location Whole cohort (n%)
Subpopulation with 
DNA-M data (n%) p-value
rs10249476 TT 127877026 Flanking 147 (13.47) 49 (14.2) 0.16
AC 5’UTR 512 (47.93) 177 (51.3)
CC 432 (39.60) 119 (34.5)
rs11763517 TT 127890062 Intron 277 (25.3) 76 (21.9) 0.26
CT 542 (49.6) 179 (51.6)
CC 274 (25.1) 92 (26.5)
rs4731429 TT 127903539 Flanking 224 (20.51) 76 (22.09) 0.44
CT 3’UTR 550 (50.37) 174 (50.58)
CC 318 (29.12) 94 (27.33)
rs10954176 TT 127907319 Flanking 319 (29.4) 93 (27) 0.43
CT 3’UTR 508 (46.8) 164 (48)
CC 258 (23.8) 86 (25.1)
Figure 4. The positions of CpG sites and SNPs included in this study, relative to the LEP gene. CDS=coding se-
quence, UTR=untranslated region.
with FEV1, FEV1/FVC, and FEF25-75% at age 18 
such that they decreased as methylation in- 
creased for the CT genotype compared to the 
TT and CC genotype of rs11763517 (Table 4). 
To demonstrate the effect of this interaction 
between a SNP and a continuous variable (lin-
ear association), we categorized the methyla-
tion values into six categories, ≤39%, 39% to 
41%, 41% to 43%, 43% to 45%, 45% to 47%, 
47% to 49% and assessed the effect of each 
category, not requiring a linear association. The 
plots indicate that, there is a decline in FEV1, 
FEV1/FVC ratio, and FEF25-75% among sub-
jects with the CT genotype when the methyla-
tion level of cg00666422 was above 45% 
(Figure 2A-C).
None of the other associations of CpG and SNP 
interaction terms with markers of lung function 
nor eNO or leptin levels measured at age 18 
survived FDR correction. However, the same 
CpG site and SNP interaction found at age 18 
years (cg00666422 × rs11763517 CT vs TT 
and CC) was significantly associated with FEV1/
FVC and FEF25-75% in the same direction 
detected at age 10 (Table 5).
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Table 5. Interaction effect of LEP CpG and SNP on FEV1, FEV1/
FVC, and FEF25-75% in girls at 10 years of Age in IOW cohort
Parameter Genotype Estimate Standard Error p-value
FEV1
rs11763517 CT 0.99 0.61 0.12
CT+TT Ref. Ref.
cg00666422 1.25 0.96 0.2
cg00666422*rs11763517 CT -2.23 1.33 0.11 
CC+TT Ref. Ref.
FEV1/FVC
rs11763517 CT 0.27 0.13 0.045
CT+TT Ref. Ref.
cg00666422 0.47 0.20 0.03
cg00666422*rs11763517 CT -0.64 0.27 0.03
CC+TT Ref. Ref.
FEF25-75%
rs11763517 CT 3.25 1.39 0.03
CT+TT Ref. Ref.
cg00666422 4.62 2.18 0.04
cg00666422*rs11763517 CT -7.42 3.01 0.02
CC+TT Ref. Ref.
*Adjusted for maternal asthma, paternal asthma, maternal smoking, height, 
and weight at age 10.
on asthma: Next, we checked wh- 
ether the cg00666422 × rs1176- 
3517 interaction had any effect on 
asthma at 18 years of age in men 
and women. We used a log-line- 
ar Poisson regression model with 
robust error variance to estimate 
the risk ratios for asthma. The mo- 
del was weighted by sex and ad- 
justed for maternal asthma, pater-
nal asthma, maternal smoking, cu- 
rrent smoking, height, weight, and 
sex of the participant. The interac-
tion of cg00666422 and rs1176- 
3517 (CT vs. TT and CC) was signifi-
cantly associated with the risk of 
asthma at age 18 (Table 7). To 
demonstrate the risk of asthma at 
specific levels of methylation, we 
estimated the risk ratios for 37%, 
39%, 41%, 43%, 45%, 47% and 
49% (Figure 3). For subjects of 
genotype CT, the risk of asthma 
steadily increased as methylation 
levels increased, relative to the 
combined TT and CC genotypes. 
The relative risk (RR) for asthma is 
Table 4. Interaction effect of LEP CpG and SNP on FEV1, FEV1/FVC and 
FEF25-75% at 18 years of Age* (FDR adjusted) in IOW cohort
Parameter Genotype Estimate Standard Error p-value
FDR p-
value
FEV1
rs11763517 CT 1.14 0.39 0.0003
CT+TT Ref. Ref.
cg00666422 2.01 0.6 0.001
cg00666422*rs11763517 CT -3.20 0.85 0.0002 0.03
CC+TT Ref. Ref.
FEV1/FVC
rs11763517 CT 0.25 0.06 0.0002
CT+TT Ref. Ref.
cg00666422 0.36 0.10 0.0005
cg00666422*rs11763517 CT -0.57 0.14 0.000071 0.0096
CC+TT Ref. Ref.
FEF25-75%
rs11763517 CT 3.94 0.85 0.000006
CT+TT Ref. Ref.
cg00666422 5.72 1.32 0.00002
cg00666422*rs11763517 CT -8.93 1.86 0.000003 0.00048
CC+TT Ref. Ref.
*Adjusted for maternal asthma, paternal asthma, maternal smoking, current smoking, 
height, and weight at age 18, and weighted for sex.
Since circulating leptin 
hormone levels differ be- 
tween men and women, 
we stratified our analysis 
for the CpG and SNP pairs 
showing significant asso-
ciations with lung func-
tion, by sex. We found 
that SNPs and CpG sites 
were significantly associ-
ated with the FEV1/FVC 
ratio and FEF25-75% only 
in women. However, the 
effect size and the direc-
tion was the same for 
both men and women 
(Table 6). Thus, this CpG 
× SNP interaction, alth- 
ough not statistically sig-
nificant in a smaller sam-
ple of men, has a similar 
effect in both men and 
women for the outcomes 
FEV1/FVC ratio and FE- 
F25-75%.
Effect of LEP SNPs, DNA-
M, and their interaction 
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lower (RR=0.3) if methylation is below 45% and 
higher thereafter (close to RR=2 if the methyla-
tion is 49%).
The BAMSE cohort
The CpG site cg00666422 and the SNP 
rs11763517 that were found to be significantly 
associated with lung function and asthma in 
66422 × rs11763517 (CT vs. TT and CC) with 
FEV1/FVC as in Isle of Wight (Table 10). For 
boys and girls at age 16, this interaction term 
showed the same direction of association for 
FEV1/FVC, and FEF25-75% in both the cohorts 
(Table 11). The values of both these lung func-
tion markers decreased with increasing meth-
ylation for the CT genotype compared to the TT 
and CC genotype of rs11763517. However, 
Table 6. Interaction of LEP CpGs and SNPs on FEV1, FEV1/FVC and FEF25-75% at 18 years of age 
(stratified by sex) in IOW cohort*
Outcome Genotype Males Females
Estimate (S.E.) p-value Estimate (S.E.) p-value
FEV1
rs11763517 CT 0.75 (0.86) 0.38 1.6 (0.44) 0.0003
CC+TT Ref. Ref. Ref. Ref.
cg00666422 2.20 (1.29) 0.09 2.05 (0.69) 0.0031
cg00666422*rs11763517 CT -1.72 (1.86) 0.36 -3.51 (0.95) 0.0003
CC+TT Ref. Ref. Ref. Ref.
FEV1/FVC
rs11763517 CT 0.16 (0.13) 0.24 0.27 (0.08) 0.0004
CC+TT Ref. Ref. Ref. Ref.
cg00666422 0.28 (0.2) 0.17 0.38 (0.12) 0.0015
cg00666422*rs11763517 CT -0.30 (0.29) 0.30 -0.63 (0.16) 0.0002
CC+TT Ref. Ref. Ref. Ref.
FEF25-75%
rs11763517 CT 2.76 (1.97) 1.16 4.25 (0.94) <0.0001
CC+TT Ref. Ref. Ref. Ref.
cg00666422 5.73 (2.97) 0.06 6.06 (1.48) <0.0001
cg00666422*rs11763517 CT -5.62 (4.27) 0.19 -9.66 (2.05) <0.0001
CC+TT Ref. Ref. Ref. Ref.
*Adjusted for maternal asthma, paternal asthma, maternal smoking, current smoking, height, and weight at age 18.
Table 7. *Effect of the interaction term of the CpG site and 
SNP on asthma at age 18 in IOW cohort
Asthma at age 18 Genotype Estimate Standard error p value
cg00666422 -6.59 3.66 0.072
rs11763517 CT -6.28 2.20 0.004
CC+TT Ref. Ref. Ref.
cg00666422 × rs11763517 CT 13.76 4.82 0.004
CC+TT Ref. Ref. Ref.
*Adjusted for maternal asthma, paternal asthma, maternal smoking, current 
smoking, height, and weight at age 18.
the Isle of Wight cohort were tested 
in the BAMSE cohort. The methyla-
tion level of this CpG site in BAMSE 
cohort ranged from 0.27 to 0.54 
(median=0.42). In this cohort, cg- 
00666422 × rs11763517 (CT vs. TT 
and CC) was not significantly associ-
ated with lung function markers. At 
age 8, DNA-M, FEV1, and FEV1/FVC 
measurements were available for 
boys and girls (Table 9). Although 
not significant, the results revealed 
same direction of association of cg006- 
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opposite effect was found for the interaction 
term on FEV1 at ages 8 and 16.
Discussion
Our findings indicate that the interaction of gen-
otype at LEP rs11763517 with DNA methyla-
tion at cg00666422 contributed to a decrease 
in FEV1, FEV1/FVC ratio, and FEF25-75%, and 
increased the risk of asthma at 18 years of age 
in the Isle of Wight birth cohort. The CpG site 
cg00666422 is located in the LEP 5’UTR and is 
8622 base pairs (bp) away from the SNP 
rs11763517 located in the first intron (Figure 
4). Additionally, this CpG is moderately methyl-
ated and has high variance in methylation 
(Table 2, Figure 5), suggesting that it may be 
more susceptible to changes in methylation 
triggered by environmental exposures. There 
have been prior studies suggesting a role of 
LEP SNPs on asthma [27], however, this is the 
first study to integrate the genetic and epigen-
etic factors and demonstrate that the methyla-
tion of the CpG site cg00666422 influences 
the penetrance of the SNP rs11763517 affect-
ing lung function and asthma.
Participants for DNA-M analysis at age 18 were 
randomly selected from the cohort, limiting the 
chances of selection bias in the study. No dif-
ferences other than sex were observed between 
the participants in the whole cohort and those 
in whom DNA-M was measured. We assessed 
more women than men at age 18 for DNA-M 
analysis due to a research focus on potential 
future pregnancy. To counter this imbalance, all 
regression models were weighted by sex. The 
probability of misclassification biases for asth-
ma is low since asthma status was defined 
by clinical investigators based on accepted 
criteria.
A limitation of this study is that both lung func-
tion and DNA-M were measured at a single time 
Table 8. *Effect of the interaction term of the CpG site and SNP on FEV1, FEV1/FVC, FEF25-75%, and 
asthma at age 18, stratified by atopy in IOW cohort
Outcome Genotype
Atopic individuals (n=239) Non-atopic individuals (n=126)
Estimate (S.E.) p-value Estimate (S.E.) p-value
FEV1
rs11763517 CT 1.61 (0.74) 0.033 1.19 (0.51) 0.02
CC+TT Ref. Ref. Ref. Ref.
cg00666422 2.14 (1.12) 0.06 1.95 (0.79) 0.015
cg00666422*rs11763517 CT -3.86 (1.58) 0.02 -2.65 (1.13) 0.019
CC+TT Ref. Ref. Ref. Ref.
FEV1/FVC
rs11763517 CT 0.17 (0.12) 0.18 2.28 (0.08) 0.0008
CC+TT Ref. Ref.
cg00666422 0.27 (0.19) 0.15 0.38 (0.13) 0.0029
cg00666422*rs11763517 CT -0.39 (0.26) 0.14 -0.63 (0.18) 0.0006
CC+TT Ref. Ref.
FEF25-75%
rs11763517 CT 2.99 (1.69) 0.08 4.12 (1.08) 0.0002
CC+TT Ref. Ref. Ref. Ref.
cg00666422 4.51 (2.55) 0.08 6.17 (1.68) 0.0003
cg00666422*rs11763517 CT -7.18 (3.59) 0.05 -9.14 (2.39) 0.0002
CC+TT Ref. Ref. Ref. Ref.
Asthma at age 18
cg00666422 -3.25 (4.77) 0.50 -8.27 (4.03) 0.04
rs11763517 CT -1.94 (2.82) 0.49 -10.30 (4.80) 0.03
rs11763517 CC+TT Ref. Ref. Ref. Ref.
cg00666422*rs11763517 CT 5.08 (6.02) 0.40 20.68 (10.06) 0.04
CC+TT Ref. Ref. Ref. Ref.
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point, which constrains our abil-
ity to determine if DNA-M is a 
consequence or a cause of the 
outcomes under study [28]. We 
addressed this with our study of 
a subset of participants at age 
10 years and we found a hi- 
gh intra-class correlation coeffi-
cient (ICC=0.85) between the 
DNA-M of cg00666422 in a 
subset of n=34 girls between 
ages 10 and 18. Also, the mean, 
median, and 5th and 95th per-
centiles of methylation values 
for this CpG were similar be- 
tween ages 10 and 18 (me- 
an=0.46, median=0.47, 5th per-
centile=0.35, 95th percentile= 
0.55). This indicates that the 
DNA-M was probably estab-
Table 9. Comparison of population characteristics of participants at ages 8 and 16 in BAMSE cohort
Parameter 8 Year (n=343) 16 Year (n=294)
Height 1.32 cm [1.16 cm-1.52 cm] 1.74 cm [1.54 cm-2.04 cm]
Weight 30.16 kg [21 kg-49.2 kg] 67.41 kg [43.9 kg-107.4 kg]
FEV1 1768 [1060-2800] 3885 [2400-6530]
FVC 2075 [1240-3450] 4761 [2670-7770]
FEF25-75% NA 4.084 [1.58-8.1]
Maternal asthma
    Yes 54 42
    No 289 252
Paternal asthma
    Yes 43 38
    No 300 256
Asthma doctor diagnosis up to
    Yes 178 163
    No 165 131
Atopy
    Yes 99 138
    No 244 156
Maternal smoking
    Yes 40 31
    No 303 263
Current smoking at 16 year
    Yes NA 31
    No NA 263
Sex
    Male 187 157
    Female 156 137
Table 10. Interaction effect of LEP CpG and SNP on FEV1, and 
FEV1/FVC in both boys and girls at 8 years of age in BAMSE 
cohort
Parameter Genotype Estimate Standard Error p-value
FEV1
rs11763517 CT 0.321 0.1926 0.0967
CT+TT Ref. Ref.
cg00666422 -0.2451 0.2491 0.3257
cg00666422*rs11763517 CT 0.4786 0.4911 0.3305
CC+TT Ref. Ref.
FEV1/FVC
rs11763517 CT 0.000482 0.00601 0.93701
CT+TT Ref. Ref.
cg00666422 -0.00235 0.00785 0.76486
cg00666422*rs11763517 CT -0.09062 0.1555 0.56056
CC+TT Ref. Ref.
*Adjusted for maternal asthma, paternal asthma, maternal smoking, height, and 
weight at age 8, and weighted for sex.
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lished before age 18 and was stable before 
the study outcomes were measured, mak- 
ing reverse causation unlikely in this case. 
Additionally, the CpG site cg00666422 also 
shows a stable methylation from birth in the 
ARIES explorer dataset [29].
In the Isle of Wight study, we found that with 
increasing methylation of cg00666422, the 
interaction of the SNP (CT vs TT and CC) and 
categorized CpG leads to a decrease in FEV1, 
FEV1/FVC ratio, and FEF25-75% (Figure 2A-C). 
At 41%-43% methylation, we observed a cross-
over in lung function outcomes for the CT vs CC 
levels of this SNP.
In the BAMSE cohort, we tested the effect of 
this cg00666422 × rs11763517 on lung func- 
tion markers. Although the association was not 
significant in the BAMSE cohort, the direction 
of the effect was the same for cg00666422 × 
rs11763517 on FEV1/FVC for both ages 8 and 
16, and FEF25-75% at age 16. However, FEV1 
did not have the same direction of association 
as found in the Isle of Wight cohort.  The partial 
replication and disagreement may be explained 
Studies have shown that a decreased FEV1/
FVC ratio and FEF25-75% indicates the pres-
ence of asthma [30-32], as marked by the pres-
ence of chronic airway obstruction [33]. In our 
study we identified that the same CpG and SNP 
interaction (cg00666422 × rs11763517) that 
affects lung function is also associated with 
the risk of asthma, such that the risk of asthma 
increases with increases in DNA-M. We also 
estimated the risk at each level of DNA-M, and 
found that risk of asthma is low (RR: 0.7) if the 
methylation level is below 45% and it increases 
steadily with increasing methylation thereafter 
(RR: 2.0 for 49% methylation) (Figure 3).
The LEP gene not only plays a vital role in regu-
lating metabolism, but is also responsible for 
pro-inflammatory systemic effects and is ex- 
pressed in lung tissue [34]. For the LEP gene, 
we did not find that the SNP x CpG interaction 
(cg00666422 × rs11763517) is associated 
with serum leptin levels. Also none of the LEP 
SNPs were associated with the leptin levels. 
However, in a prior study we reported that 
genetic variants at the leptin receptor genes 
(LEPR, LEPROT) are related to serum leptin lev-
Table 11. Interaction effect of LEP CpG and SNP on FEV1, 
FEV1/FVC and FEF25-75% at 16 years of Age* in BAMSE 
cohort
Parameter Genotype Estimate Standard Error p-value
FEV1
rs11763517 CT 0.01 0.05 0.83
CT+TT Ref. Ref.
cg00666422 0.064 0.63 0.92
cg00666422*rs11763517 CT 0.37 1.26 0.77
CC+TT Ref. Ref.
FEV1/FVC
rs11763517 CT 0.004 0.008 0.619
CT+TT Ref. Ref.
cg00666422 0.019 0.097 0.84
cg00666422*rs11763517 CT -0.18 0.19 0.347
CC+TT Ref. Ref.
FEF25-75%
rs11763517 CT 0.047 0.11 0.679
CT+TT Ref. Ref.
cg00666422 0.567 1.39 0.68
cg00666422*rs11763517 CT -1.01 2.79 0.716
CC+TT Ref. Ref.
*Adjusted for maternal asthma, paternal asthma, maternal smoking, current 
smoking, height, and weight at age 16, and weighted for sex.
by different single nucleotide poly-
morphisms in linkage disequilibri-
um and/or correlated CpGs relat-
ed to lung function in both cohorts. 
In the IOW birth cohort, we focus- 
ed on rs11763517 and not rs- 
10249476; both are in linkage dis-
equilibrium (Figure 1). Also, in the 
IOW birth cohort we investigated 
the CpG site cg00666422, and 
not the two CpG sites next to this 
site: cg12782180 and cg0084- 
0332 (Figure 4). Additionally in 
the BAMSE cohort, methylation of 
cg00666422 was measured at a 
single time point at age 8. Ho- 
wever, the methylation at age 8 
may not predict the lung function 
at age 16 and this might lead to 
the difference in our results. Fur- 
ther investigation need to find out, 
whether similar interaction can be 
detected in the BAMSE cohort 
with slightly different SNPs or 
CpGs. We believe that it is unlikely 
that the IOW findings are spurious, 
since they could be replicated in 
the same cohort at a younger age.
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Table 12. Effect of the interaction term of the CpG site and SNP on FEV1, FEV1/FVC, and FEF25-75%, 
at age 16, stratified by atopy in BAMSE cohort
Outcome Genotype
Atopic individuals (n=138) Non-atopic individuals (n=156)
Estimate (S.E.) p-value Estimate (S.E.) p-value
FEV1
rs11763517 CT 0.05 (0.08) 0.52 -0.01 (0.07) 0.89
CC+TT Ref. Ref. Ref. Ref.
cg00666422 -0.94 (0.95) 0.32 1.46 (0.87) 0.097
cg00666422*rs11763517 CT 1.79 (1.87) 0.34 -0.95 (1.74) 0.584
CC+TT Ref. Ref. Ref. Ref.
FEV1/FVC
rs11763517 CT 0.02 (0.011) 0.069 -0.01 (0.01) 0.308
CC+TT Ref. Ref. Ref. Ref.
cg00666422 -0.14 (0.14) 0.33 0.22 (0.14) 0.110
cg00666422*rs11763517 CT -0.25 (0.28) 0.37 -0.05 (0.27) 0.848
CC+TT Ref. Ref. Ref. Ref.
FEF25-75%
rs11763517 CT 0.29 (0.16) 0.07 -0.16 (0.16) 0.340
CC+TT Ref. Ref. Ref. Ref.
cg00666422 -2.21 (1.97) 0.26 3.96 (2.0) 0.050
cg00666422*rs11763517 CT -0.33 (3.86) 0.93 -1.12 (3.98) 0.779 
CC+TT Ref. Ref. Ref. Ref.
*Adjusted for maternal asthma, paternal asthma, maternal smoking, current smoking, height, and weight at age 16, and 
weighted for sex.
Figure 5. Methylation levels (β values) of the LEP CpG sites.
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els [14] . Hence, it is possible that the levels of 
leptin in the serum are less regulated by the 
LEP gene but determined more by leptin recep-
tor genes. In the present analysis, we adjusted 
all models with BMI at age 18, to see whether 
BMI influences the association of the SNP and 
the CpG sites with lung function or asthma. 
However, the cg00666422 × rs11763517 in- 
teractions with FEV1/FVC, FEF25-75%, and as- 
thma were not diminished (data not shown). 
Thus, it is possible that DNA-M of the LEP modi-
fies the penetrance of its SNPs to affect lung 
function and asthma independent of BMI and 
leptin.
Regarding exhaled nitric oxide, no association 
was detected. Exhaled nitric oxide has been 
shown to be strongly associated with allergic 
sensitization (atopy) [35]. However, in the Isle 
of Wight study, we found that the combined 
effect of the LEP SNP and the LEP CpG site was 
stronger among non-atopic participants (Table 
8), which may indicate why we did not find an 
association with exhaled nitric oxide. Hence, 
our results are in concordance with findings 
that non-atopic inflammation and asthma may 
be explained by involvement of the leptin gene 
[36]. However, in the BAMSE cohort, no differ-
ence between atopic and non-atopic children 
was detected (Table 12).
In summary, our results demonstrate the im- 
portance of interactions between genetic vari-
ants and DNA methylation of the LEP gene on 
spirometric lung function markers and asthma, 
particularly in non-atopic participants. Further 
studies should explore these epigenetic mech-
anisms and investigate the biological mecha-
nism by which changes in LEP expression lead 
to asthma development. The involvement of a 
modifiable CpG site in the risk related to a sin-
gle nucleotide polymorphisms (SNP) of the LEP 
gene suggests the SNP-related gene can be 
altered.
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